Management of incidental findings in the era of next-generation sequencing

Current Genomics

Volumn 16, Issue 3, 2015, Pages 159-174

  Blackburn, Heather L ^a   Schroeder, Bradley ^a   Turner, Clesson ^b   Shriver, Craig D ^b   Ellsworth, Darrell L ^a   Ellsworth, Rachel E ^b  

^a WINDBER RESEARCH INSTITUTE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

ACMG; Disclosure; Incidental findings; Next generation sequencing

Indexed keywords

NUCLEOTIDE;

ARTICLE; BASE PAIRING; GENE AMPLIFICATION; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOME; HUMAN; METAGENOMICS; MUTATION; NEXT GENERATION SEQUENCING; PEDIATRICS; PHENOTYPE; POLICY; PRENATAL DIAGNOSIS; RESEARCH;

EID: 84928942838     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/1389202916666150317232930     Document Type: Article

References (117)

1. National Human Genome Research Institute. Gentic Timeline. http://www.genome.gov/pages/education/genetictimeline.pdf (Accessed November 26, 2014).
2. Le Dran, H. Memoire avec un precis de plusieurs observations surle cancer. Mem. Acad. R. Chir., 1757, 3, 1-54.
3. Committee on assessing genetic risks, I. o. M. Assessing Genetic Risks: Implications for Health and Social Policy; National Academies Press (US): Washington (DC), 1994.
4. National Human Genome Research Institute. Frequently askedquestions about genetic testing. http://www.genome.gov/19516567 (Accessed November 26, 2014).
5. Katsanis, S.H.; Katsanis, N. Molecular genetic testing and the future of clinical genomics. Nat. Rev. Genet. 2013,14, 415-426.
6. Biesecker, L. G.; Green, R. C. Diagnostic clinical genome and exome sequencing. N. Engl. J. Med., 2014, 370 (25), 2418-2425.
7. Sanger, F.; Nicklen, S.; Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U. S. A., 1977, 74 (12), 5463-5467.
8. Metzker, M.L. Emerging technologies in DNA sequencing. Ge-nome Res. 2005, 15(12), 1767-1776.
9. Morey, M.; Fernandez-Marmiesse, A.; Castineiras, D.; Fraga, J. M.; Couce, M. L.; Cocho, J. A. A glimpse into past, present, and future DNA sequencing. Mol. Genet. Metab., 2013,110(1-2), 3-24.
10. Liu, L.; Li, Y.; Li, S.; Hu, N.; He, Y.; Pong, R.; Lin, D.; Lu, L.; Law, M. Comparison of next-generation sequencing systems. J. Biomed. Biotechnol., 2012, 2012, 251364.
11. Rizzo, J. M.; Buck, M. J. Key principles and clinical applications of "next-generation" DNA sequencing. Cancer Prev. Res. (Phila) 2012, 5 (7), 887-900.
12. Rehm, H.L.; Bale, S.J.; Bayrak-Toydemir, P.; Berg, J.S.; Brown, K. K.; Deignan, J. L.; Friez, M. J.; Funke, B. H.; Hegde, M. R.; Lyon, E. ACMG clinical laboratory standards for next-generation sequencing. Genet. Med. 2013,15 (9), 733-747.
13. Ronaghi, M. Pyrosequencing sheds light on DNA sequencing. Genome Res. 2001,11 (1), 3-11.
14. Roche. GS FLX+ System. http://454.com/products/gs-flx-system/ index.asp (Accessed October 2, 2014).
15. Thayer, A. M. Next-Gen Sequencing Is A Numbers Game. Chemical & Engineering News, Aug 18, 2014, pp 11-15.
16. Pandey, V.; Nutter, R. C; Prediger, E. Applied Biosystems Solid System: Ligation-Based Sequencing. In Next-Generation Genome Sequencing: Towards Personalized Medicine, Janitz M, Ed.; Wiley-VCH Verlag GmbH & Co. KGaA: 2008; pp 29-41.
17. Life Technologies. SOLiD® Next-Generation Sequencing Chemistry. http://www.lifetechnologies.com/us/en/home/life-science/sequencing/next-generation-sequencing/solid-next-generation-sequencing/solid-next-generation-sequencing-systems-reagents-accessories/solid-next-generation-sequencing-chemistry.html# (Accessed October 2, 2014).
18. Huang, Y. F.; Chen, S. C; Chiang, Y. S.; Chen, T. H.; Chiu, K. P. Palindromic sequence impedes sequencing-by-ligation mechanism. BMC Syst. Biol, 2012, 6 Suppl 2, S10.
19. Life Technologies. The Chip is the Machine™. http://www.lifetechnologies.com/us/en/home/life-science/sequencing/next-generation-sequencing/ion-torrent-next-generation-sequencing-workflow/ion-torrent-next-generation-sequencing-run-sequence/ ion-pgm-ion-proton-system-chips.html(Accessed October 6, 2014).
20. Quail, M. A.; Smith, M.; Coupland, P.; Otto, T. D.; Harris, S. R.; Connor, T. R.; Bertoni, A.; Swerdlow, H. P.; Gu, Y. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics, 2012,13, 341.
21. Illumina. Sequencing by Synthesis (SBS) Technology. http://technology.illumina.com/technology/next-generation-sequencing/sequencing-technology.html (Accessed October 2, 2014).
22. Mardis, E. R. Next-generation DNA sequencing methods. Annu. Rev. Genomics Hum. Genet., 2008,9, 387-402.
23. Illumina. Illumina Sequencing Technology. http://science.illumina.com/content/dam/illumina-marketing/documents/products/techspotlights/ techspotlight_sequencing.pdf (Accessed October 3, 2014).
24. van Dijk, E. L.; Auger, H.; Jaszczyszyn, Y.; Thermes, C. Ten years of next-generation sequencing technology. Trends Genet., 2014, 30 (9), 418-426.
25. Drmanac, R.; Sparks, A. B.; Callow, M. J.; Halpern, A. L.; Burns, N. L.; Kermani, B. G.; Carnevali, P.; Nazarenko, I.; Nilsen, G. B.; Yeung, G.; Dahl, F.; Fernandez, A.; Staker, B.; Pant, K. P.; Bac-cash, J.; Borcherding, A. P.; Brownley, A.; Cedeno, R.; Chen, L.; Chernikoff, D.; Cheung, A.; Chirita, R.; Curson, B.; Ebert, J. C; Hacker, C. R.; Hartlage, R.; Hauser, B.; Huang, S.; Jiang, Y.; Karpinchyk, V.; Koenig, M.; Kong, C; Landers, T.; Le, C; Liu, J.; McBride, C. E.; Morenzoni, M.; Morey, R. E.; Mutch, K.; Perazich, H.; Perry, K.; Peters, B. A.; Peterson, J.; Pethiyagoda, C. L.; Pothuraju, K.; Richter, C; Rosenbaum, A. M.; Roy, S.; Shafto, J.; Sharanhovich, U.; Shannon, K. W.; Sheppy, C. G.; Sun, M.; Thakuria, J. V.; Tran, A.; Vu, D.; Zaranek, A. W.; Wu, X.; Drmanac, S.; Oliphant, A. R.; Banyai, W. C; Martin, B.; Ballinger, D. G.; Church, G. M.; Reid, C. A. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science, 2010, 327 (5961), 78-81.
26. Schadt, E. E.; Turner, S.; Kasarskis, A. A window into third-generation sequencing. Hum. Mol. Genet., 2010, 19(2R), R227-R240.
27. Mikheyev, A. S.; Tin, M. M. A first look at the Oxford Nanopore MinION sequencer. Mol. Ecol. Resour., 2014,14(6), 1097-1102.
28. Hewitt, J. MinION USB stick gene sequencer finally comes to market. http://www.extremetech.com/extreme/190409-minion-usb-stick-gene-sequencer-finally-comes-to-market (Accessed October 6, 2014).
29. Lohmann, K.; Klein, C. Next Generation Sequencing and the Future of Genetic Diagnosis. Neurotherapeutics 2014, 11(4), 699-707.
30. Roberts, J. S.; Dolinoy, D. C; Tarini, B. A. Emerging issues in public health genomics. Annu. Rev. Genomics Hum. Genet., 2014, 15, 461-480.
31. Khatoon, Z.; Figler, B.; Zhang, H.; Cheng, F. Introduction to RNA-Seq and its applications to drug discovery and development. Drug Dev. Res. 2014, 75 (5), 324-330.
32. Curnutte, M. A.; Frumovitz, K. L.; Bollinger, J. M.; McGuire, A. L.; Kaufman, D. J. Development of the clinical next-generation sequencing industry in a shifting policy climate. Nat. Biotechnol, 2014, 32(10), 980-982.
33. Check, W. Next-gen sequencing in clinical debuts. http://www.cap.org/apps/cap.portal?_nfpb=true&cntvwrPtlt_actionOverride=%2Fportlets%2FcontentViewer%2Fshow&_windowLabel=cntvwrPtlt&cntvwrPtlt%7BactionForm.contentReference%7D=cap_today%2F0411%2F0411a_next_gen.html&_state=maximized&_pag eLabel=cntvwr (Accessed September 22, 2014).
34. Illumina. TruGenome Clinical Sequencing Services for Patients/ Guardians. http://clinical.illumina.com/clinical/illumina_clinical_laboratory/igs_for_patients.html (Accessed October 6, 2014).
35. Duke Center for Personalized and Precision Medicine. Clinical Sequencing. www.dukepersonalizedmedicine.org (Accessed October 10, 2014).
36. Gene by Gene. Research and Consumer Genetics. www.genebygene.com (Accessed October 15, 2014).
37. Ambry Genetics. Exome Sequencing: ExomeNext and Exome Next-Rapid. www.ambrygen.com/exomenext (Accessed October 15, 2014).
38. Davies, K. Advances in Clinical Genomic Sequencing and Diag-nostitcs. http://www.insightpharmareports.com/reports_ re-port.aspx?id=124496&r=11285 (Accessed September 22, 2014).
39. National Human Genome Research Institute. NIH Undiagnosed Diseases Program. www.genome.gov/27544402(Accessed October 15, 2014).
40. Rare Genomics Institute. Who We Are. http://raregenomics.org (Accessed October 15, 2014).
41. Cohen, M.M. Variability versus "incidental findings" in the first and second branchial arch syndrome: unilateral variants with anophthalmia. Birth Defects Orig. Artic. Ser. 1971, 7(7), 103-108.
42. Colcock, B. P. Routine general explorations of the abdomen in all laparotomies; incidental findings. Lahey Clin. Bull. 1951, 7(6), 173-176.
43. Kendall, J.L.; Mandavia, D. Incidental findings during emergency sonographic examinations: a case series. CJEM, 2001, 3(2), 105-108.
44. Oz, A.; Oguz, B.; Karcaaltincaba, M.; Yilmaz, M.; Haliloglu, M. Incidentally detected congenital giant left atrial appendage aneurysm in a child: MRI findings. JBR. -BTR. 2014, 97(1), 30-32.
45. Morgan, L.G.; Gardner, J.; Calkins, J. The incidental finding of a persistent left superior vena cava: implications for primary care providers-case and review. Case. Rep. Med. 2015, 2015, 198754.
46. Mirza, S.; Malik, T.H.; Ahmed, A.; Willatt, D.J.; Hughes, D. G. Incidental findings on magnetic resonance imaging screening for cerebellopontine angle tumors. J. Larynolog. Otol, 2000, 114(10), 750-754.
47. Cho, M. K. Understanding incidental findings in the context of genetics and genomics. J. Law Med. Ethics, 2008, 36(2), 280-5, 212.
48. Turney, L. The incidental discovery of nonpaternity through genetic carrier screening: an exploration of lay attitudes. Qual. Health Res., 2005,15 (5), 620-634.
49. Van, N.B. Genomic research and incidental findings. J. Law Med. Ethics, 2008, 36(2), 292-7, 212.
50. Reilly, P. R.; Boshar, M. F.; Holtzman, S. H. Ethical issues in genetic research: disclosure and informed consent. Nat. Genet., 1997,15 (1), 16-20.
51. National Bioethics Advisory Commission Research involving human biological materials: ethical issues and policy guid-ance;Volume 1; Rockville, MD, 1999.
52. Wolf, S. M.; Lawrenz, F. P.; Nelson, C. A.; Kahn, J. P.; Cho, M. K.; Clayton, E. W.; Fletcher, J. G.; Georgieff, M. K.; Hammer-schmidt, D.; Hudson, K.; Illes, J.; Kapur, V.; Keane, M. A.; Koe-nig, B. A.; Leroy, B. S.; McFarland, E. G.; Paradise, J.; Parker, L. S.; Terry, S. F.; Van, N. B.; Wilfond, B. S. Managing incidental findings in human subjects research: analysis and recommendations. J. Law Med. Ethics, 2008, 36(2), 219-48, 211.
53. Hens, K.; Nys, H.; Cassiman, J. J.; Dierickx, K. The return of individual research findings in paediatric genetic research. J. Med. Ethics, 2011, 37(3), 179-183.
54. Simon, C. M.; Williams, J. K.; Shinkunas, L.; Brandt, D.; Daack-Hirsch, S.; Driessnack, M. Informed consent and genomic incidental findings: IRB chair perspectives. J. Empir. Res. Hum. Res. Ethics, 2011, 6(4), 53-67.
55. Williams, J.K.; Daack-Hirsch, S.; Driessnack, M.; Downing, N.; Shinkunas, L.; Brandt, D.; Simon, C. Researcher and institutional review board chair perspectives on incidental findings in genomic research. Genet. Test. Mol. Biomarkers, 2012,16(6), 508-513.
56. Fabsitz, R. R.; McGuire, A.; Sharp, R. R.; Puggal, M.; Beskow, L. M.; Biesecker, L. G.; Bookman, E.; Burke, W.; Burchard, E. G.; Church, G.; Clayton, E. W.; Eckfeldt, J. H.; Fernandez, C. V.; Fisher, R.; Fullerton, S. M.; Gabriel, S.; Gachupin, F.; James, C; Jarvik, G. P.; Kittles, R.; Leib, J. R.; O'Donnell, C; O'Rourke, P. P.; Rodriguez, L. L.; Schully, S. D.; Shuldiner, A. R.; Sze, R. K.; Thakuria, J. V.; Wolf, S. M.; Burke, G. L. Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ. Cardiovasc. Genet., 2010, 3(6), 574-580.
57. Bunnik, E. M.; Schermer, M. H.; Janssens, A. C. Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues. BMC. Med. Ethics, 2011,12, 11.
58. Krier, J. B.; Green, R. C. Management of incidental findings in clinical genomic sequencing. Curr. Protoc. Hum. Genet., 2013, Chapter 9, Unit 9.
59. ten Bosch, J. R.; Grody, W. W. Keeping up with the next generation: massively parallel sequencing in clinical diagnostics. J. Mol. Diagn. 2008,10(6), 484-492.
60. Shahmirzadi, L.; Chao, E. C; Palmaer, E.; Parra, M. C; Tang, S.; Gonzalez, K. D. Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing. Genet. Med., 2014,16(5), 395-399.
61. Goddard, K. A.; Whitlock, E. P.; Berg, J. S.; Williams, M. S.; Webber, E. M.; Webster, J. A.; Lin, J. S.; Schrader, K. A.; Campos-Outcalt, D.; Offit, K.; Feigelson, H. S.; Hollombe, C. Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies. Genet. Med., 2013,15(9), 721-728.
62. Berg, J. S.; Khoury, M. J.; Evans, J. P. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet. Med., 2011,13(6), 499-504.
63. Berg, J. S.; Adams, M.; Nassar, N.; Bizon, C; Lee, K.; Schmitt, C. P.; Wilhelmsen, K. C; Evans, J. P. An informatics approach to analyzing the incidentalome. Genet. Med., 2013,15(1), 36-44.
64. Kullo, I. J.; Haddad, R.; Prows, C. A.; Holm, I.; Sanderson, S. C; Garrison, N. A.; Sharp, R. R.; Smith, M. E.; Kuivaniemi, H.; Bot-tinger, E.P.; Connolly, J.J.; Keating, B.J.; McCarty, C.A.; Williams, M. S.; Jarvik, G. P. Return of results in the genomic medicine projects of the eMERGE network. Front. Genet., 2014, 5, 50.
65. Jarvik, G.P.; Amendola, L.M.; Berg, J.S.; Brothers, K.; Clayton, E. W.; Chung, W.; Evans, B.J.; Evans, J.P.; Fullerton, S.M.; Gallego, C.J.; Garrison, N.A.; Gray, S.W.; Holm, I.A.; Kullo, I.J.; Lehmann, L.S.; McCarty, C; Prows, C.A.; Rehm, H.L.; Sharp, R.R.; Salama, J.; Sanderson, S.; Van Driest, S.L.; Williams, M.S.; Wolf, S.M.; Wolf, W.A.; Burke, W. Return of genomic results to research participants: the floor, the ceiling, and the choices in between. Am. J. Hum. Genet, 2014, 94(6), 818-826.
66. Teutsch, S. M.; Bradley, L. A.; Palomaki, G. E.; Haddow, J. E.; Piper, M.; Calonge, N.; Dotson, W. D.; Douglas, M. P.; Berg, A. O. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet. Med., 2009,11(1), 3-14.
67. Aziz, N.; Zhao, Q.; Bry, L.; Driscoll, D. K.; Funke, B.; Gibson, J. S.; Grody, W. W.; Hegde, M. R.; Hoeltge, G. A.; Leonard, D. G.; Merker, J. D.; Nagarajan, R.; Palicki, L. A.; Robetorye, R. S.; Schrijver, I.; Weck, K. E.; Voelkerding, K. V. College of American Pathologists' Laboratory Standards for Next-Generation Sequencing Clinical Tests. Arch. Pathol. Lab Med., 2014.
68. Green, R. C; Berg, J. S.; Grody, W. W.; Kalia, S. S.; Korf, B. R.; Martin, C. L.; McGuire, A. L.; Nussbaum, R. L.; O'Daniel, J. M.; Ormond, K. E.; Rehm, H. L.; Watson, M. S.; Williams, M. S.; Biesecker, L. G. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 2013,15(7), 565-574.
69. Ross, L. F.; Saal, H. M.; David, K. L.; Anderson, R. R. Technical report: Ethical and policy issues in genetic testing and screening of children. Genet. Med., 2013, 15(3), 234-245.
70. Wolf, S. M.; Annas, G. J.; Elias, S. Respecting patient autonomy in clinical genomics: new recommendations on incidental findings go astray. Science, 2013, 340(6136), 1049-1050.
71. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet. Med., 2014.
72. Burke, W.; Antommaria, A. H.; Bennett, R.; Botkin, J.; Clayton, E. W.; Henderson, G. E.; Holm, I. A.; Jarvik, G. P.; Khoury, M. J.; Knoppers, B. M.; Press, N. A.; Ross, L. F.; Rothstein, M. A.; Saal, H.; Uhlmann, W. R.; Wilfond, B.; Wolf, S. M.; Zimmern, R. Recommendations for returning genomic incidental findings? We need to talk! Genet. Med., 2013, 15(11), 854-859.
73. Allyse, M.; Michie, M. Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing. Tr. Biotechnol. 2013, 31(8), 439-441.
74. Bell, C. J.; Dinwiddie, D. L.; Miller, N. A.; Hateley, S. L.; Ganu-sova, E. E.; Mudge, J.; Langley, R. J.; Zhang, L.; Lee, C. C; Schilkey, F. D.; Sheth, V.; Woodward, J. E.; Eckham, H. E.; Schroth, G. P.; Kim, R. W.; Kingsmore, S. F. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci. Transl. Med., 2011, 3(65), 65ra4.
75. Royal, C. D.; Novembre, J.; Fullerton, S. M.; Goldstein, D. B.; Long, J. C; Bamshad, M. J.; Clark, A. G. Inferring genetic ancestry: opportunities, challenges, and implications. Am. J. Hum. Genet., 2010, 86(5), 661-673.
76. Fiorentino, F.; Bono, S.; Biricik, A.; Nuccitelli, A.; Cotroneo, E.; Cottone, G.; Kokocinski, F.; Michel, C. E.; Minasi, M. G.; Greco, E. Application of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preim-plantation genetic screening cycles. Hum. Reprod., 2014, 29(12), 2802-2813.
77. Kuliev, A. Practical preimplantation genetic diagnosis; Second ed.; Springer-Verlag: London, 2012.
78. Scott, R. T.; Ferry, K.; Su, J.; Tao, X.; Scott, K.; Treff, N. R. Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study. Fertil Steril 2012, 97 (4), 870-875.
79. Simpson, J. L.; Rechitsky, S.; Kuliev, A. Next-generation sequencing for preimplantation genetic diagnosis. Fertil. Steril. 2013, 99 (5), 1203-1204.
80. Treff, N. R.; Fedick, A.; Tao, X.; Devkota, B.; Taylor, D.; Scott, R. T., Evaluation of targeted next-generation sequencing-based preimplantation genetic diagnosis of monogenic disease. Fertil. Steril. 2013, 99 (5), 1377-1384.
81. Wells, D.; Kaur, K.; Grifo, J.; Glassner, M.; Taylor, J. C; Fragouli, E.; Munne, S. Clinical utilisation of a rapid low-pass whole genome sequencing technique for the diagnosis of aneuploidy in human embryos prior to implantation. J. Med. Genet., 2014, 51(8), 553-562.
82. Fiorentino, F.; Biricik, A.; Bono, S.; Spizzichino, L.; Cotroneo, E.; Cottone, G.; Kokocinski, F.; Michel, C. E. Development and validation of a next-generation sequencing-based protocol for 24-chromosome aneuploidy screening of embryos. Fertil. Steril, 2014, 101(5), 1375-1382.
83. Mujezinovic, F.; Alfirevic, Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet. Gynecol, 2007, 110(3), 687-694.
84. Birch, L.; English, C. A.; O'Donoghue, K.; Barigye, O.; Fisk, N. M.; Keer, J. T. Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin. Chem., 2005, 51(2), 312-320.
85. Bustamante-Aragones, A.; Rodriguez de, A. M.; Perlado, S.; Tru-jillo-Tiebas, M. J.; Arranz, J. P.; Diaz-Recasens, J.; Troyano-Luque, J.; Ramos, C. Non-invasive prenatal diagnosis of single-gene disorders from maternal blood. Gene, 2012, 504(1), 144-149.
86. Wright, C. F.; Burton, H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod. Update, 2009, 15(1), 139-151.
87. The American College of Obstetricians and Gynecologists Committee on Genetics and The Society for Maternal-Fetal Medicine Publications Committee. Noninvasive Prenatal Testing for Fetal Aneuploidy. http://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Genetics/Noninvasive-Prenatal-Testing-for-Fetal-Aneuploidy (Accessed December 22, 2014).
88. Chervenak, F. A.; McCullough, L. B. Perinatal ethics: a practical method of analysis of obligations to mother and fetus. Obstet. Gynecol, 1985, 66(3), 442-446.
89. Johnston, J. J.; Rubinstein, W. S.; Facio, F. M.; Ng, D.; Singh, L. N.; Teer, J. K.; Mullikin, J. C; Biesecker, L. G. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am. J. Hum. Genet., 2012, 91(1), 97-108.
90. American Academy of Pediatrics. AAP Issues New Guidance on Genetic Testing of Children. http://www.aap.org/en-us/about-the-aap/aap-press-room/Pages/AAP-Issues-New-Guidance-on-Genetic-Testing-of-Children.aspx (Accessed December 8, 2014).
91. Boycott, K. M.; Vanstone, M. R.; Bulman, D. E.; MacKenzie, A. E. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat. Rev. Genet. 2013,14 (10), 681-691.
92. Lawrence, L.; Sincan, M.; Markello, T.; Adams, D. R.; Gill, F.; Godfrey, R.; Golas, G.; Groden, C; Landis, D.; Nehrebecky, M.; Park, G.; Soldatos, A.; Tifft, C; Toro, C; Wahl, C; Wolfe, L.; Gahl, W. A.; Boerkoel, C. F. The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience. Genet. Med., 2014, 16(10), 741-750.
93. May, T.; Zusevics, K. L.; Strong, K. A. On the ethics of clinical whole genome sequencing of children. Pediatrics 2013, 132 (2), 207-209.
94. Abdul-Karim, R.; Berkman, B. E.; Wendler, D.; Rid, A.; Khan, J.; Badgett, T.; Hull, S.C. Disclosure of incidental findings from next-generation sequencing in pediatric genomic research. Pediatrics, 2013, 131 (3), 564-571.
95. American College of Medical Genetics and Genomics Incidental findings in clinical genomics: a clarification. Genet. Med. 2013, 15 (8), 664-666.
96. Shkedi-Rafid, S.; Dheensa, S.; Crawford, G.; Fenwick, A.; Lucas-sen, A. Defining and managing incidental findings in genetic and genomic practice. J. Med. Genet., 2014, 51(11), 715-723.
97. Beaulieu, C. L.; Majewski, J.; Schwartzentruber, J.; Samuels, M. E.; Fernandez, B. A.; Bernier, F. P.; Brudno, M.; Knoppers, B.; Marcadier, J.; Dyment, D.; Adam, S.; Bulman, D. E.; Jones, S. J.; Avard, D.; Nguyen, M. T.; Rousseau, F.; Marshall, C; Wintle, R. F.; Shen, Y.; Scherer, S. W.; Friedman, J. M.; Michaud, J. L.; Boycott, K. M. FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project. Am. J. Hum. Genet. 2014, 94(6), 809-817.
98. Knoppers, B.M. Paediatric research and the communication of not-so incidental findings. Paediatr. Child Health, 2012, 17(4), 190-192.
99. Fernandez, C.V.; Strahlendorf, C; Avard, D.; Knoppers, B. M.; O'Connell, C; Bouffet, E.; Malkin, D.; Jabado, N.; Boycott, K.; Sorensen, P. H. Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting. Genet. Med., 2013, 15(7), 558-564.
100. Bowdin, S.; Ray, P.N.; Cohn, R.D.; Meyn, M.S. The genome clinic: a multidisciplinary approach to assessing the opportunities and challenges of integrating genomic analysis into clinical care. Hum. Mutat., 2014, 35(5), 513-519.
101. Shkedi-Rafid, S.; Fenwick, A.; Dheensa, S.; Lucassen, A. M. Genetic testing of children for adult-onset conditions: opinions of the British adult population and implications for clinical practice. Eur. J. Hum. Genet. 2014.
102. Ambry Genetics. CancerNext. http://www.ambrygen.com/print/tests/cancernext(Accessed December 18, 2014).
103. Faita, F.; Vecoli, C; Foffa, I.; Andreassi, M. G. Next generation sequencing in cardiovascular diseases. World J. Cardiol, 2012, 4 (10), 288-295.
104. Keogh, M. J.; Chinnery, P. F. Next generation sequencing for neurological diseases: new hope or new hype? Clin. Neurol. Neuro-surg. 2013, 115 (7), 948-953.
105. Lemke, A. A.; Bick, D.; Dimmock, D.; Simpson, P.; Veith, R. Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: a survey study. Clin. Genet. 2013, 84 (3), 230-236.
106. Kurian, A. W.; Kingham, K. E.; Ford, J. M. Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment. Curr. Opin. Obstet. Gynecol, 2014, 27 (1), 23-33.
107. Biesecker, B. B.; Klein, W.; Lewis, K. L.; Fisher, T. C; Wright, M. F.; Biesecker, L. G.; Han, P. K. How do research participants perceive "uncertainty" in genome sequencing? Genet. Med., 2014, 16 (12), 977-980.
108. Kalia, M. Biomarkers for personalized oncology: recent advances and future challenges. Metabolism 2014, 64 (3 Suppl 1), S16-S21.
109. Parsons, D. W.; Roy, A.; Plon, S. E.; Roychowdhury, S.; Chinnai-yan, A. M. Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings. J. Clin. Oncol, 2014, 32 (21), 2203-2205.
110. Ross, J. S.; Wang, K.; Elkadi, O. R.; Tarasen, A.; Foulke, L.; Shee-han, C. E.; Otto, G. A.; Palmer, G.; Yelensky, R.; Lipson, D.; Chmielecki, J.; Ali, S. M.; Elvin, J.; Morosini, D.; Miller, V. A.; Stephens, P. J. Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer. J. Clin. Pathol, 2014, 67(9), 772-776.
111. Sehn, L. H.; Gascoyne, R. D. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. Blood, 2014.
112. Catenacci, D. V.; Amico, A. L.; Nielsen, S. M.; Geynisman, D. M.; Rambo, B.; Carey, G. B.; Gulden, C; Fackenthal, J.; Marsh, R. D.; Kindler, H. L.; Olopade, O. I. Tumor genome analysis includes germline genome: Are we ready for surprises? Int. J. Cancer, 2014.
113. Boers, S. N.; van Delden, J. J.; Knoers, N. V.; Bredenoord, A.L. Postmortem disclosure of genetic information to family members: active or passive? Trends Mol. Med., 2015, 21(3), 148-153.
114. Clayton, E. W.; Haga, S.; Kuszler, P.; Bane, E.; Shutske, K.; Burke, W. Managing incidental genomic findings: legal obligations of clinicians. Genet. Med., 2013, 15(8), 624-629.
115. Clayton, E. W.; McGuire, A. L. The legal risks of returning results of genomics research. Genet. Med., 2012,14(4), 473-477.
116. Brown, S. M. Sequencing-by-Synthesis: Explaining the Illumina Sequencing Technology. http://bitesizebio.com/13546/sequencing-by-synthesis-explaining-the-illumina-sequencing-technology/ (Accessed October 29, 2014).
117. Bui, T. H.; Raymond, F. L.; Van den Veyver, I. B. Current controversies in prenatal diagnosis 2: should incidental findings arising from prenatal testing always be reported to patients? Prenat. Di-agn., 2014, 34 (1), 12-17.